Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingxing Hu

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Materials Chemistry. B|April 8, 2020
A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cellsMingxing Hu, Chao Yang, Yi Luo, et al.
Journal of Medicinal Chemistry|November 20, 2025
Discovery of Novel LAT1-Targeted PET Tracers from <sup>18</sup>F-Labeled Aromatic Amino Acids via Photocatalyzed <sup>18</sup>F-FluorinationYang Xie, Yueqi Wang, Mingxing Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 3, 2016
Punica granatum (pomegranate) leaves extract induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in non-small cell lung cancer in vitroYali Li, Fangfang Yang, Weidong Zheng, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|September 24, 2009
Image guidance for robotic minimally invasive coronary artery bypassMichael Figl, Daniel Rueckert, David Hawkes, et al.
Journal of Medicinal Chemistry|May 29, 2026
Structural Optimization of NET-Targeted Agents: <i>ortho</i>-Radioiodinated Phenoxyalkylguanidine Achieves Enhanced Tumor Retention and Radiotherapeutic EfficacyXijian Chen, Lili Pan, Yueqi Wang, et al.
Journal of Nanobiotechnology|June 25, 2026
Virus-like particles in cancer immunotherapy: bridging human and veterinary medicine through one healthYingqi Zhu, Zhuangli Bi, Zichen Zhang, et al.
Molecular Biomedicine|December 19, 2022
An overview of PROTACs: a promising drug discovery paradigmZi Liu, Mingxing Hu, Yu Yang, et al.
Acta Pharmaceutica Sinica. B|March 6, 2023
A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrenceTao He, Mingxing Hu, Shunyao Zhu, et al.
Acta Pharmaceutica Sinica. B|November 9, 2020
Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1Mingxing Hu, Weilin Zhou, Yijie Wang, et al.
Frontiers in Pharmacology|June 26, 2024
Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer's disease model miceDongping Yao, Ting Li, Lu Yu, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Materials Chemistry. B|April 8, 2020
A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cellsMingxing Hu, Chao Yang, Yi Luo, et al.
Journal of Medicinal Chemistry|November 20, 2025
Discovery of Novel LAT1-Targeted PET Tracers from <sup>18</sup>F-Labeled Aromatic Amino Acids via Photocatalyzed <sup>18</sup>F-FluorinationYang Xie, Yueqi Wang, Mingxing Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 3, 2016
Punica granatum (pomegranate) leaves extract induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in non-small cell lung cancer in vitroYali Li, Fangfang Yang, Weidong Zheng, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|September 24, 2009
Image guidance for robotic minimally invasive coronary artery bypassMichael Figl, Daniel Rueckert, David Hawkes, et al.
Journal of Medicinal Chemistry|May 29, 2026
Structural Optimization of NET-Targeted Agents: <i>ortho</i>-Radioiodinated Phenoxyalkylguanidine Achieves Enhanced Tumor Retention and Radiotherapeutic EfficacyXijian Chen, Lili Pan, Yueqi Wang, et al.
Journal of Nanobiotechnology|June 25, 2026
Virus-like particles in cancer immunotherapy: bridging human and veterinary medicine through one healthYingqi Zhu, Zhuangli Bi, Zichen Zhang, et al.
Molecular Biomedicine|December 19, 2022
An overview of PROTACs: a promising drug discovery paradigmZi Liu, Mingxing Hu, Yu Yang, et al.
Acta Pharmaceutica Sinica. B|March 6, 2023
A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrenceTao He, Mingxing Hu, Shunyao Zhu, et al.
Acta Pharmaceutica Sinica. B|November 9, 2020
Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1Mingxing Hu, Weilin Zhou, Yijie Wang, et al.
Frontiers in Pharmacology|June 26, 2024
Selective degradation of hyperphosphorylated tau by proteolysis-targeting chimeras ameliorates cognitive function in Alzheimer's disease model miceDongping Yao, Ting Li, Lu Yu, et al.
Pageof 6